Albumin and interferon-β fusion protein serves as an effective vaccine adjuvant to enhance antigen-specific CD8+ T cell-mediated antitumor immunity

BACKGROUND: Type I interferons (IFN) promote dendritic cells maturation and subsequently enhance generation of antigen-specific CD8 +T cell for the control of tumor. Using type I interferons as an adjuvant to vaccination could prove to be a potent strategy. However, type I interferons have a short h...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Ssu-Hsueh, Cheng, Max A, Farmer, Emily, Ferrall, Louise, Kung, Yu Jui, Lam, Brandon, Lim, Ling, Wu, T-C, Hung, Chien-Fu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036441/
https://www.ncbi.nlm.nih.gov/pubmed/35459734
http://dx.doi.org/10.1136/jitc-2021-004342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9036441/
https://www.ncbi.nlm.nih.gov/pubmed/35459734
http://dx.doi.org/10.1136/jitc-2021-004342

Ejemplares similares